Validation Study of Frontier X Plus (FX+) Device

Not yet recruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

January 20, 2025

Study Completion Date

April 20, 2025

Conditions
Atrial Fibrillation
Interventions
DEVICE

FX+ and 12-Lead ECG Recording

While lying down, subjects will wear the FX+, a chest strap device which will measure cardiac electrical activity to generate a continuous heart rate measurement. Simultaneously, electrodes for the 12-Lead ECG will be placed on the chest and arms/legs to record the electrical activity. Two 30-second recordings from the FX+ will be taken simultaneously with the 12-lead ECG with no more than a 3-minute interval between the two recordings.

All Listed Sponsors
collaborator

University of Rochester

OTHER

lead

Fourth Frontier Technologies Pvt Ltd.

INDUSTRY

NCT06471764 - Validation Study of Frontier X Plus (FX+) Device | Biotech Hunter | Biotech Hunter